Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
These 3 Nail-Free Finds Completely Transformed My Drab Bathroom- Ghassan Al-Duhaini to replace Abu Shabab as Popular Forces leader in Gaza
- Winter storms blanket the East, while the U.S. West is wondering: Where’s the snow?
- 6 Hints to Upgrade Your Appeal, In addition to Your Outlook
- Soldiers seize power in Guinea-Bissau and detain the president
- Astonishing interstellar comet captured in new images by NASA Mars missions
- Instructions to Investigate Different Open Record Extra Offers Actually
- Figure out How to Adjust Your Handshake to Various Societies
- Find the Interesting Universe of Computerized reasoning: the Capability of man-made intelligence
